Alcohol Use Disorder Market by Treatment Type, Disorder Type, Distribution Channel

List of Tables

[198 Pages Report] The Alcohol Use Disorder Market size was estimated at USD 1.21 billion in 2023 and expected to reach USD 1.28 billion in 2024, at a CAGR 6.50% to reach USD 1.88 billion by 2030.

The market for Alcohol Use Disorder (AUD) encompasses a range of products, therapies, and services dedicated to the diagnosis, treatment, and management of AUD, characterized by a reduced ability to control or stop alcohol use despite adverse consequences. The rising awareness of AUD as a treatable condition is leading to higher diagnosis and treatment rates. The advancements in treatment options including new pharmaceuticals and digital therapeutics, enhance the efficacy and accessibility of alcohol use disorder. The increasing health care expenditure globally, with a growing focus on mental health and substance abuse disorders, contributes the market growth. However, limited accessibility to treatment facilities and high costs associated with comprehensive care may limit the market growth. Regulatory hurdles in the approval and adoption of new therapies and digital health solutions may pose challenges in the market. Moreover, the expansion of telehealth services to reach underserved populations and provide continuous, remote support contributes to the market growth. The development of personalized treatment plans leveraging genetic, behavioral, and environmental data to improve outcomes are creating new avenues in the market.

KEY MARKET STATISTICS
Base Year [2023]	USD 1.21 billion
Estimated Year [2024]	USD 1.28 billion
Forecast Year [2030]	USD 1.88 billion
CAGR (%)	6.50%

Treatment Type: Rising preference for behavioral therapies to effectively control alcohol use disorder

Behavioral Therapy involves counseling that educates individuals about strategies to reduce or stop alcohol use, including techniques such as Motivational Enhancement Therapy (MET), Cognitive-Behavioral Therapy (CBT), and Family Therapy. Detoxification safely withdraws alcohol from the body, often under the supervision of healthcare professionals, to effectively manage withdrawal symptoms. Inpatient rehabilitation programs offer intensive Therapy and support in a controlled environment, typically lasting 30 to 90 days, including medical supervision, counseling, and aftercare planning. Medication is suited for individuals looking for a biological approach to assist in reducing alcohol intake or maintaining abstinence, often in conjunction with other treatment forms.

Distribution Channel: Increasing utilization of over-the-counter medications by retail pharmacies to support recovery

Hospital pharmacies are critical in the distribution of medications for alcohol use disorder, particularly for inpatient care and immediate post-discharge prescriptions. Patients with severe AUD conditions often require hospitalization. Here, hospital pharmacies serve as the first point of contact for obtaining prescribed medications, ensuring continuous care from inpatient to outpatient treatment phases. Retail pharmacies and drug stores are accessible points of medication acquisition for patients managing AUD on an outpatient basis. Patients in the maintenance phase of AUD treatment, or those with mild to moderate conditions, frequently utilize retail pharmacies for their medication needs.

Regional Insights

In the Americas region, alcohol use disorder affects a significant portion of the adult population. Recent patents in drug formulations and digital interventions for AUD treatment show a trend towards personalization and non-invasive therapies in the Americas region. Ongoing investments are notably directed towards biotechnology firms focusing on novel medication and holistic treatment methods in the region. European countries show a diverse landscape regarding AUD, with northern countries generally exhibiting higher rates of alcohol consumption. The EU has introduced regulations and initiatives to combat alcohol misuse, with a notable push towards integrating health services. Innovation in the EMEA region has been seen in alcohol monitoring devices and AI-driven predictive analytics for personalized treatment plans. The Middle East has a relatively lower prevalence of AUD due to cultural and religious factors. Africa faces unique challenges with AUD, linked to socio-economic factors and the availability of informal alcohol markets. In the APAC region, China's rapid urbanization and economic growth have been mirrored by increasing alcohol consumption and AUD rates. In Japan, societal pressures and work culture contribute to alcohol consumption patterns, reflecting a focus on pharmaceutical interventions and innovative therapy models, including virtual reality (VR) environments for therapy.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Alcohol Use Disorder Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Alcohol Use Disorder Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Alcohol Use Disorder Market, highlighting leading vendors and their innovative profiles. These include Addex Therapeutics, Adial Pharmaceuticals, Alkermes, Astellas Pharma, Beckley Psytech Limited, BioCorRx, Inc., Bioprojet, Clairvoyant Therapeutics, Corcept Therapeutics Inc., GlaxoSmithKline PLC, Indivior Inc., Kinnov Therapeutics, Kinoxis Therapeutics, Lundbeck, MediciNova, Merck & Co. Inc., Omeros Corporation, Otsuka Pharmaceuticals, Sun Pharmaceutical Industries Limited, and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Alcohol Use Disorder Market to forecast the revenues and analyze trends in each of the following sub-markets:

Treatment Type
- Behavioral Therapy
- Detoxification
- Inpatient Rehabilitation
- Medication

Disorder Type
- Alcohol Abuse
- Alcohol Dependence
- High-Functioning Alcoholism

Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies & Drug Stores

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam

Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Alcohol Use Disorder Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Alcohol Use Disorder Market?

3. What are the technology trends and regulatory frameworks in the Alcohol Use Disorder Market?

4. What is the market share of the leading vendors in the Alcohol Use Disorder Market?

5. Which modes and strategic moves are suitable for entering the Alcohol Use Disorder Market?

Product Code: MRR-351BAD503A27

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increasing incidences of substance abuse cases across the world
  - 5.1.1.2. Government initiatives and schemes to prevent, diagnose, and treat alcohol abuse disorder
  - 5.1.1.3. Proliferation of digital and telehealth strategies for preventing and managing alcohol use
- 5.1.2. Restraints
  - 5.1.2.1. Performance limitations and complexities in evaluating efficiency
- 5.1.3. Opportunities
  - 5.1.3.1. Research initiatives and advancements to improve the efficacy and efficiency of alcohol use disorder therapeutics and diagnostics
  - 5.1.3.2. Ongoing approvals for devices, drugs, and formulations that help manage alcohol use
- 5.1.4. Challenges
  - 5.1.4.1. Complexities in developing alcohol use disorder therapeutics and diagnostics strategies
5.2. Market Segmentation Analysis
- 5.2.1. Treatment Type: Rising preference for behavioral therapies to effectively control alcohol use disorder
- 5.2.2. Distribution Channel: Increasing utilization of over-the-counter medications by retail pharmacies to support recovery
5.3. Market Disruption Analysis
5.4. Porter's Five Forces Analysis
- 5.4.1. Threat of New Entrants
- 5.4.2. Threat of Substitutes
- 5.4.3. Bargaining Power of Customers
- 5.4.4. Bargaining Power of Suppliers
- 5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis

6. Alcohol Use Disorder Market, by Treatment Type

6.1. Introduction
6.2. Behavioral Therapy
6.3. Detoxification
6.4. Inpatient Rehabilitation
6.5. Medication

7. Alcohol Use Disorder Market, by Disorder Type

7.1. Introduction
7.2. Alcohol Abuse
7.3. Alcohol Dependence
7.4. High-Functioning Alcoholism

8. Alcohol Use Disorder Market, by Distribution Channel

8.1. Introduction
8.2. Hospital Pharmacies
8.3. Retail Pharmacies & Drug Stores

9. Americas Alcohol Use Disorder Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Alcohol Use Disorder Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Alcohol Use Disorder Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
- 12.3.1. Researchers Receive USD 3.4 Million Grant to Study Alcohol Use Disorder Among People with Disabilities
- 12.3.2. Affect Raises USD 16 Million As Addiction-Related Financings Hold Strong
- 12.3.3. Indivior Completes Acquisition of Opiant Pharmaceuticals, Inc.
12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

13.1. Key Company Profiles
13.2. Key Product Portfolio